Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The endothelial integrity, as mechanical barrier against microorganisms and as natural "anticoagulant", is crucial for physiologic organ function. Systemic activation of the endothelium upon inflammation, sepsis, and septic shock is always ending in blood-tissue barrier disruption. With increasing dysfunction, uncontrolled clotting activation, capillary microthrombi formation, tissue edema, local hypoxia, and ischemia are initiated. This in turn enhances a vicious circle leading to multiple organ failure and death. Therefore, biomarkers reflecting this special compartment may help in the early detection of systemic inflammation and its complications. This review provides an overview of the most important endothelial biomarkers and their possible use in sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients
Ferreira, F. L. (2001) · JAMA · doi:10.1001/jama.286.14.1754 · Cited by 2,862
Taylor, F., Toh, C.-H., Hoots, K., Wada, H., & Levi, M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616068 · Cited by 2,285 · cited 1×
“…that may vary greatly from a simple drop in platelet counts or subclinical prolongation in clotting times to the full picture of a disseminated intravascular coagulation (DIC) and, finally ends up in a global consumption of clotting factors (Levi 2007; Levi and Ten Cate 1999; Taylor et al. 2001).”
BackgroundIsolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989 · cited 1×
“The angiopoietins (Ang)-1 and -2 belong to the family of growth factors and have been studied mainly in proliferative diseases such as cancer (neoangiogenesis) (Davis et al. 1996; Fiedler and Augustin 2006; Maisonpierre et al. 1997; Suri et al. 1996).”
BackgroundFibrinogen and fibrin structure and functions
MOSESSON, M. W. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01365.x · Cited by 1,695
Selectins and their ligands: Current concepts and controversies
Kansas, G. (1996) · Blood · doi:10.1182/blood.v88.9.3259.bloodjournal8893259 · Cited by 1,415
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933 · cited 2×
“Other small clinical studies demonstrated that circulating Ang-2 levels correlated with the APACHE and SOFA scoring systems as well as with the 28-day mortality reflecting disease severity and prognosis (Fiedler et al. 2006; Kranidioti et al. 2009; McCarter et al. 2007; Orfanos et al. 2007; Thurston et al. 2000; Thurs…”
BackgroundMethodEndothelial-Mural Cell Signaling in Vascular Development and Angiogenesis
Gaengel, K., Genové, G., Armulik, A., & Betsholtz, C. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.161521 · Cited by 933
Epidemiology of sepsis: an update
Angus, D. C., & Wax, R. S. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00035 · Cited by 813
Angiopoietins: a link between angiogenesis and inflammation
Fiedler, U., & Augustin, H. G. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.004 · Cited by 606
Role of PDGF in fibrotic diseases and systemic sclerosis
Trojanowska, M. (2008) · Rheumatology · doi:10.1093/rheumatology/ken265 · Cited by 213
Cell-based Angiopoietin-1 Gene Therapy for Acute Lung Injury
McCarter, S. D., Mei, S. H. J., Lai, P. F. H., Zhang, Q. W., Parker, C. H., Suen, R. S., Hood, R. D., Zhao, Y. D., Deng, Y., Han, R. N. N., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200609-1370oc · Cited by 154 · cited 2×
“Other small clinical studies demonstrated that circulating Ang-2 levels correlated with the APACHE and SOFA scoring systems as well as with the 28-day mortality reflecting disease severity and prognosis (Fiedler et al. 2006; Kranidioti et al. 2009; McCarter et al. 2007; Orfanos et al. 2007; Thurston et al. 2000; Thurs…”
BackgroundMethod
Cited by
Faix, J. D. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.764490 · Cited by 663
Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells
Li, M., van Esch, B. C. A. M., Wagenaar, G. T. M., Garssen, J., Folkerts, G., & Henricks, P. A. J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.003 · Cited by 614
Glycocalyx and sepsis-induced alterations in vascular permeability
Chelazzi, C., Villa, G., Mancinelli, P., De Gaudio, A. R., & Adembri, C. (2015) · Critical Care · doi:10.1186/s13054-015-0741-z · Cited by 389
Aldecoa, C., Llau, J. V., Nuvials, X., & Artigas, A. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00697-1 · Cited by 253
Point-of-care sensors for the management of sepsis
Reddy, B., Hassan, U., Seymour, C., Angus, D. C., Isbell, T. S., White, K., Weir, W., Yeh, L., Vincent, A., & Bashir, R. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0288-9 · Cited by 142
Metadata
- Authors
- Paulus, P., Jennewein, & Zacharowski, K.
- Venue
- Biomarkers
- Publisher
- Informa UK Limited
- Published
- 2011-06-28
- Volume
- 16
- Issue
- sup1
- Pages
- S11-S21
- ISSN
- 1354-750X (ISSN-L)
- 1366-5804
- OpenAlex
- W2068796527
- Cited by
- 194
- References
- 11
- FWCI
- 9.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.